Skip to content
DeepViews

The Cooper Companies, Inc. Common Stock (COO) — 分析摘要

The Cooper Companies, Inc. Common Stock(COO)的市值为10.56十亿美元,最近一年的营收同比增长了+5.1%。净利润率为9.2%。当前市盈率为18.5倍。

核心要点

  • 营收同比变化+5.1%
  • 净利润率9.2%
  • 市盈率18.5倍

与OPHTHALMIC GOODS板块的其他公司相比,COO的营收增长为+5.1%,市盈率为18.5倍。

[XNAS]

The Cooper Companies, Inc. Common Stock (COO)

$55.55

前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$10.56B
企业价值
$12.32B
市盈率
18.5
股息率
0.11%
EV/EBITDA
13.3
公司简介
关于
关于 The Cooper Companies, Inc. Common Stock

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

行业

OPHTHALMIC GOODS

员工人数

15,000

总部

SAN RAMON, CA

Exchange

XNAS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
64
窄护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$8328.40M
总债务$1916.10M
债务权益比0.23
现金及等价物$154.70M

现金流

经营现金流$1033.30M
自由现金流$678.00M
自由现金流率16.00%
P/FCF 比率15.58
Source: Polygon.io · SEC EDGAR
股息
股息

年度每股股息

$0.06

股息收益率

0.11%

半年度
最近除息日: 2023-07-26

股息历史

2023-07-26
CD$0.0300
2023-01-20
CD$0.0300
2022-07-26
CD$0.0300
2022-01-20
CD$0.0300
Source: Polygon.io
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。